NCT02481258: A trial that was reported late by Mayo Clinic
This trial has reported, although it was 36 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT02481258 |
|---|---|
| Title | A Phase II Randomized, Placebo-Controlled, Double-Blinded Study Evaluating the Effects of Ataciguat (HMR1766) on Aortic Valve Calcification in Patients With Moderate Calcific Aortic Valve Stenosis |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | June 30, 2015 |
| Completion date | July 1, 2018 |
| Required reporting date | July 1, 2019, midnight |
| Actual reporting date | Aug. 6, 2019 |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | 36 |